Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century

Author:

Tichanek Filip12ORCID,Försti Asta34ORCID,Liska Vaclav15,Hemminki Akseli67ORCID,Hemminki Kari18ORCID

Affiliation:

1. Biomedical Center, Faculty of Medicine, Charles University Pilsen, 30605 Pilsen, Czech Republic

2. Institute of Pathological Physiology, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic

3. Hopp Children’s Cancer Center (KiTZ), 69120 Heidelberg, Germany

4. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69210 Heidelberg, Germany

5. Department of Surgery, School of Medicine in Pilsen, University Hospital, 30605 Pilsen, Czech Republic

6. Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland

7. Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland

8. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany

Abstract

Background: Survival studies in intestinal cancers have generally shown favorable development, but few studies have been able to pinpoint the timing of the changes in survival over an extended period. Here, we compared the relative survival rates for colon, rectal and small intestinal cancers from Denmark (DK), Finland (FI), Norway (NO) and Sweden (SE). Design: Relative 1-, 5- and 5/1-year conditional survival data were obtained from the NORDCAN database for the years 1971–2020. Results: The 50-year survival patterns were country-specific. For colon and rectal cancers, the slopes of survival curves bended upwards for DK, were almost linear for NO and bended downwards for FI and SE; 5-year survival was the highest in DK. Survival in small intestinal cancer was initially below colon and rectal cancers but in FI and NO it caught up toward the end of the follow-up. Conclusions: Relative survival in intestinal cancers has developed well in the Nordic countries, and DK is an example of a country which in 20 years was able to achieve excellent survival rates in colon and rectal cancers. In the other countries, the increase in survival curves for colon and rectal cancer has slowed down, which may be a challenge posed by metastatic cancers.

Funder

European Union’s Horizon 2020 research and innovation program

Jane and Aatos Erkko Foundation

Sigrid Juselius Foundation

Finnish Cancer Organizations

University of Helsinki

Helsinki University Central Hospital

Novo Nordisk Foundation

Päivikki and Sakari Sohlberg Foundation

Finnish Red Cross Blood Service

SURG and National Institute for Cancer Research—NICR

European Union—Next Generation EU

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference44 articles.

1. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964–2003 followed up to the end of 2006;Klint;Acta Oncol.,2010

2. Ocasio Quinones, G.A., and Woolf, A. (2021). Small Bowel Cancer, StatPearls Publishing.

3. Kumar, V., Cotran, R., and Robbins, S. (1997). Basic Pathology, W.B. Saunders.

4. Familial gastrointestinal carcinoid tumours and associated cancers;Hiripi;Ann. Oncol.,2009

5. Time trends in incidence and survival of small intestinal cancer in Sweden;Landerholm;BJS Open,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3